John McGready Selected Research

John McGready Research Topics

2	Pruritus (Itching) 01/2006 - 04/2005
2	Nausea 01/2006 - 04/2005
2	Vomiting 01/2006 - 04/2005
2	Pain (Aches) 01/2006 - 04/2005
1	Type 2 Diabetes Mellitus (MODY) 05/2024
1	Weight Loss (Weight Reduction) 05/2024
1	Body Weight (Weight, Body) 08/2023
1	Critical Illness (Critically Ill) 01/2023
1	Dementia (Dementias) 11/2022
1	Hypothyroidism 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 12/2016
1	Thyrotoxicosis 09/2015
1	Smith-Lemli-Opitz Syndrome 11/2012
1	Hepatitis 09/2012
1	Chronic Hepatitis B 09/2012
1	Inflammation (Inflammations) 06/2012
1	Postoperative Pain 01/2006
1	Liver Diseases (Liver Disease) 05/2005
1	Infections 05/2005
1	Gallstones (Gallstone) 05/2005
1	Cerebral Palsy (Spastic Diplegia) 03/2005

5	Thyroid HormonesIBA 08/2023 - 09/2015
2	Insulin (Novolin)FDA Link 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 09/2012
2	Opioid Analgesics (Opioids)IBA 01/2006 - 04/2005
1	Hemoglobins (Hemoglobin)IBA 05/2024
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022
1	meglitinideIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	ChloridesIBA 12/2016
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2016
1	CholesterolIBA 11/2012
1	MercuryIBA 09/2012
1	Glatiramer Acetate (Copaxone)FDA Link 06/2012
1	BilirubinIBA 05/2005
1	Serum AlbuminIBA 05/2005
1	RNA (Ribonucleic Acid)IBA 05/2005
1	Morphine (MS Contin)FDA LinkGeneric 04/2005
1	Naloxone (Narcan)FDA LinkGeneric 04/2005
1	Type A Botulinum Toxins (Botox)FDA Link 03/2005

1	Therapeutics 09/2015
1	Analgesia 01/2006
1	Cholecystectomy 05/2005
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 04/2005